EPIC-CP: Expanded Prostate Cancer Index Composite for Clinical Practice
As survivorship after prostate cancer (PCa) diagnosis continues to improve with advances in detection and treatment, the effects of PCa treatment on health-related quality of life (HRQOL) are becoming increasingly important. The changes in HRQOL for each PCa treatment modality are well-recognized, but objective characterization and quantification of such changes are challenging. A validated tool that would be practical for use in both community and academic clinical practices, for use specifically in patients with prostate cancer has not yet been realized. Hence, we set out to develop and validate a shorter and more accessible HRQOL instrument designed specifically for use in the routine clinical care of prostate cancer patients.
Download the EPIC-CP instrument using the link below: